This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

George F. Murphy, MD

Arch Dermatol. 1985;121(6):731-733.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In an editorial that appeared in the ARCHIVES over two years ago, Berger and Edelson¹ described the clinical utility of monoclonal antibodies that are primarily directed against T-cell differentiation antigens. Since that time, literally thousands of studies have emerged that examine the application of novel polyclonal and monoclonal antibody reagents to practical and research-related settings. The use of immunocytochemistry in the evaluation of biopsy tissue is now an accepted adjunct to tumor diagnosis in many pathology laboratories. In this issue of the ARCHIVES, a number of articles underscore our growing dependence on these techniques for understanding pathogenetic mechanisms of inflammatory dermatoses, defining histogenetic relationships in certain cutaneous neoplasms, enhancing diagnostic accuracy and efficiency, and monitoring therapeutic responses.

IMMUNOCYTOCHEMISTRY OF INFLAMMATORY DERMATOSES

The prototype of many cutaneous inflammatory disorders is the delayed hypersensitivity response. In this reaction, antigens, either exogenous or endogenous, are presented by dendritic cells . . . [Full Text PDF of this Article]

Author Affiliations
Department of Pathology Brigham and Women's Hospital 75 Francis St Boston, MA 02115

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?